TIL
Instil Bio Inc.
NASDAQ: TIL · HEALTHCARE · BIOTECHNOLOGY
$7.85
-2.85% today
Updated 2026-04-29
Market cap
$54.80M
P/E ratio
—
P/S ratio
54,248.82x
EPS (TTM)
$-10.70
Dividend yield
—
52W range
$6 – $43
Volume
0.0M
Instil Bio Inc. (TIL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $9.48M | $319.01M | $609.98M | $482.13M | $325.63M | $263.57M |
| Cash & equivalents | $8.89M | $241.71M | $37.59M | $43.72M | $9.20M | $8.80M |
| Current assets | $9.29M | $246.14M | $464.02M | $269.38M | $160.76M | $124.47M |
| Total liabilities | $1.42M | $26.64M | $54.78M | $118.52M | $99.80M | $94.13M |
| Current liabilities | $1.42M | $13.28M | $41.36M | $32.79M | $10.56M | $7.90M |
| Long-term debt | — | — | — | $72.35M | $81.43M | $84.19M |
| Shareholder equity | $8.06M | $292.37M | $555.20M | $363.61M | $225.83M | $169.44M |
| Retained earnings | $-7.18M | $-44.92M | $-201.72M | $-424.89M | $-580.98M | $-655.12M |
| Accounts receivable | — | $3.17M | $8.14M | — | — | $2.62M |
| Inventory | — | $1.18M | — | — | — | — |
| Goodwill | $0.00 | $5.72M | $5.72M | $0.00 | — | — |